WO2000054776A1 - Utilisation d'inhibiteurs de la prolactine dans le traitement des problemes de fecondite dans diverses especes animales - Google Patents
Utilisation d'inhibiteurs de la prolactine dans le traitement des problemes de fecondite dans diverses especes animales Download PDFInfo
- Publication number
- WO2000054776A1 WO2000054776A1 PCT/IB1999/000448 IB9900448W WO0054776A1 WO 2000054776 A1 WO2000054776 A1 WO 2000054776A1 IB 9900448 W IB9900448 W IB 9900448W WO 0054776 A1 WO0054776 A1 WO 0054776A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- prolactin inhibitor
- animal species
- cabergoline
- fertility problems
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Definitions
- the present invention is concerned with the use of a medicament in the treatment of fertility problems in various animal species. Furthermore the invention is concerned with a method for a treatment of fertility problems with said medicament.
- the postpartum period is associated with fertility problems in many species (1) .
- the problem has been highlighted some time ago (2) . Allusion has been made at that time to under- nutrition. However undernutrition is not specific for the postpartum period.
- lacta- tional anoestrus Eigenmann, J.E.
- Such cows on rectal palpation exhibit a corpus luteum persistens, an ovarian cyst or nothing (Acyclia) .
- Gestagens include intravaginal devices or oral forms. Intravaginal devices often induce vaginitis and oral forms are time consuming.
- this Gestagen treatment which is also called synchronization method is derived from the synchronization of normal young. animals. In cows undergoing Gestagen treatment a new oestrus should appear approximately 3-10 days after withdrawal. Not uncommonly prostaglandin F2 ⁇ is administered in order to remove any residual corpus luteum tissue. Hence the treatment is expensive, nonspecific and most likely unsuccessful in many cases. 30 - 40% of premature slaughtering is due to unresolved fertility problems (3) .
- prolactin which is important in the development of the mammary gland, is said by some veterinarians to be of no importance in milk production there are no good data to reject the hypothesis that specifically in the postpartum period prolactin induces and/or maintains a high milk yield. It is strongly believed that it must be Prolactin which inhibits LH-secretion leading to ovarian dysfunction (6, 7, 8) .
- a further object of the present invention has been a method for the treatment of said fertility problems which is, due to the characterics of the medicament according to the present invention, less time consuming and which allows an easier application of said mediament.
- This object has been achieved by administering a prolactin inhibitor to anovulatory animal species in the PP period.
- alkaloids Due to their specific effect, especially on the nervous system, alkaloids are a well known class of substances widely used in pharmacology. Examples for such alkaloids are, beside others, caffeine, morphine, strychnine, colchicine, and the socalled ergot alkaloids.
- Ergot (Claviceps purpurea) is a filamentous fungus growing on various types of grain, especially secale. Ergot alkaloids have been used in the past as labour stimulating and uterus contracting agents.
- these substances are applied inter alia in cancer treatment.
- Biller et al. (6) used Cabergoline (Pharmacia, Columbus, OH), an ergotamine derivative specific for the D2 receptor, for the treatment of prolactinomas, the most commonly occuring pituarity tumour in men.
- Dostinex (Pharmacia & UpJohn/Cabergoline) (7) was chosen. The compound was pulverized and 2x10, 9, 8 and 3,5 mg were dissolved in 20 ml 0,9%-ige NaCl. The compound was administered into the uterus. Each catheter was rinsed with another 20 ml NaCl.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU26355/99A AU2635599A (en) | 1999-03-17 | 1999-03-17 | Use of prolactin inhibitors for the treatment of fertility problems in animal species |
PCT/IB1999/000448 WO2000054776A1 (fr) | 1999-03-17 | 1999-03-17 | Utilisation d'inhibiteurs de la prolactine dans le traitement des problemes de fecondite dans diverses especes animales |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB1999/000448 WO2000054776A1 (fr) | 1999-03-17 | 1999-03-17 | Utilisation d'inhibiteurs de la prolactine dans le traitement des problemes de fecondite dans diverses especes animales |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000054776A1 true WO2000054776A1 (fr) | 2000-09-21 |
Family
ID=11004835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB1999/000448 WO2000054776A1 (fr) | 1999-03-17 | 1999-03-17 | Utilisation d'inhibiteurs de la prolactine dans le traitement des problemes de fecondite dans diverses especes animales |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2635599A (fr) |
WO (1) | WO2000054776A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2936710A1 (fr) * | 2008-10-07 | 2010-04-09 | Ceva Sante Animale | Composition veterinaire antiprolactinique destinee aux ruminants |
US20200375980A1 (en) * | 2018-01-30 | 2020-12-03 | Ceva Sante Animale | Veterinary antiprolactinic composition |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3959288A (en) * | 1974-12-13 | 1976-05-25 | Eli Lilly And Company | 8-Oxymethylergolines and process therefor |
US3985752A (en) * | 1974-12-06 | 1976-10-12 | Eli Lilly And Company | 6-Methyl-8-(substituted) methylergolines |
FR2336135A1 (fr) * | 1975-12-23 | 1977-07-22 | Sandoz Sa | Nouveaux derives de l'ergoline, leur preparation et leur application comme medicaments |
US4054660A (en) * | 1975-04-14 | 1977-10-18 | Eli Lilly And Company | Method of inhibiting prolactin |
EP0003286A2 (fr) * | 1978-01-20 | 1979-08-08 | Sandoz Ag | Dérivés d'alcaloides ergopeptidiques, procédé pour leur préparation et compositions pharmaceutiques les contenant |
EP0003667A1 (fr) * | 1978-02-08 | 1979-08-22 | Eli Lilly And Company | Dérivés de l'ergoline, leur préparation et compositions pharmaceutiques les contenant |
GB2173699A (en) * | 1985-04-05 | 1986-10-22 | Poli Ind Chimica Spa | Pharmaceutical compositions with antilactational activity |
EP0781774A2 (fr) * | 1995-12-08 | 1997-07-02 | Takeda Chemical Industries, Ltd. | Inhibiteurs de la synthèse de prolactin |
-
1999
- 1999-03-17 WO PCT/IB1999/000448 patent/WO2000054776A1/fr active Search and Examination
- 1999-03-17 AU AU26355/99A patent/AU2635599A/en not_active Abandoned
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3985752A (en) * | 1974-12-06 | 1976-10-12 | Eli Lilly And Company | 6-Methyl-8-(substituted) methylergolines |
US3959288A (en) * | 1974-12-13 | 1976-05-25 | Eli Lilly And Company | 8-Oxymethylergolines and process therefor |
US4054660A (en) * | 1975-04-14 | 1977-10-18 | Eli Lilly And Company | Method of inhibiting prolactin |
FR2336135A1 (fr) * | 1975-12-23 | 1977-07-22 | Sandoz Sa | Nouveaux derives de l'ergoline, leur preparation et leur application comme medicaments |
EP0003286A2 (fr) * | 1978-01-20 | 1979-08-08 | Sandoz Ag | Dérivés d'alcaloides ergopeptidiques, procédé pour leur préparation et compositions pharmaceutiques les contenant |
EP0003667A1 (fr) * | 1978-02-08 | 1979-08-22 | Eli Lilly And Company | Dérivés de l'ergoline, leur préparation et compositions pharmaceutiques les contenant |
GB2173699A (en) * | 1985-04-05 | 1986-10-22 | Poli Ind Chimica Spa | Pharmaceutical compositions with antilactational activity |
EP0781774A2 (fr) * | 1995-12-08 | 1997-07-02 | Takeda Chemical Industries, Ltd. | Inhibiteurs de la synthèse de prolactin |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2936710A1 (fr) * | 2008-10-07 | 2010-04-09 | Ceva Sante Animale | Composition veterinaire antiprolactinique destinee aux ruminants |
WO2010040765A1 (fr) * | 2008-10-07 | 2010-04-15 | Ceva Sante Animale Sa | Composition veterinaire antiprolactinique destinee aux ruminants |
CN102215843A (zh) * | 2008-10-07 | 2011-10-12 | 诗华动物保健股份有限公司 | 用于反刍动物的抗催乳素兽医学组合物 |
JP2012505178A (ja) * | 2008-10-07 | 2012-03-01 | セヴァ・サンテ・アニマル | 反芻動物のための獣医用抗プロラクチン組成物 |
AU2009301134B2 (en) * | 2008-10-07 | 2013-12-05 | Ceva Sante Animale Sa | Antiprolactinic veterinary composition for ruminants |
RU2528892C2 (ru) * | 2008-10-07 | 2014-09-20 | Сева Санте Анималь Са | Ветеринарная антипролактиновая композиция для жвачных |
US9730923B2 (en) | 2008-10-07 | 2017-08-15 | Ceva Sante Animale | Antiprolactinic veterinary composition for ruminants |
US9744158B2 (en) | 2008-10-07 | 2017-08-29 | Ceva Sante Animale | Veterinary antiprolactinic composition for ruminants |
KR101892559B1 (ko) * | 2008-10-07 | 2018-08-28 | 세바상뜨 아니말르 사 | 반추 동물용 항프롤락틴성 수의학적 조성물 |
US20200375980A1 (en) * | 2018-01-30 | 2020-12-03 | Ceva Sante Animale | Veterinary antiprolactinic composition |
Also Published As
Publication number | Publication date |
---|---|
AU2635599A (en) | 2000-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tabares et al. | Pharmacological overview of galactogogues | |
US9763962B2 (en) | Estrus synchronization preparations and effective CIDR-less protocols | |
Blanchard et al. | Estrous cycle characteristics and response to estrus synchronization in mammoth asses (Equus asinus americanus) | |
JP2007210995A (ja) | アヘン剤拮抗物質およびカルシウム塩を含む薬剤組成物、エンドルフィン介在病状の治療のためのこれらの使用法 | |
Contreras‐Villarreal et al. | Reproductive performance of seasonally anovular mixed‐bred dairy goats induced to ovulate with a combination of progesterone and eCG or estradiol | |
DK2349272T3 (da) | Veterinær anti-prolaktin-sammensætning til drøvtyggere | |
Heersche Jr et al. | Synchronization of estrus in beef heifers with a norgestomet implant and prostaglandin F2α | |
Gobello | Revisiting canine pseudocyesis | |
US4880632A (en) | Prevention of fescue toxicosis | |
JP2016508030A (ja) | 未経産ブタにおける授精の時期を同期化するための方法および組成物 | |
Hart | The relationship between lactation and the release of prolactin and growth hormone in the goat | |
Brown et al. | Reproductive response of beef cows to exogenous progestogen, estrogen and gonadotropins at various stages postpartum | |
EP2424527B1 (fr) | Stabilisateurs de mastocytes utilisés pour prévenir ou traiter la fourbure | |
Saxena et al. | Induction of ovulation in anestrus ewes using a dopamine receptor antagonist | |
WO2000054776A1 (fr) | Utilisation d'inhibiteurs de la prolactine dans le traitement des problemes de fecondite dans diverses especes animales | |
US4673665A (en) | Process for treating anestrus in ewes or beef cattle | |
Black et al. | Effect of oxytocin, epinephrine and atropine on the oestrous cycle of the cow | |
Cook et al. | Influence of cortisol and dexamethasone on estrous behavior of estradiol-treated ovariectomized cows and heifers | |
Collu | Endocrine effects of chronic intraventricular administration of Δ9-tetrahydrocannabinol to prepuberal and adult male rats | |
CN101267826B (zh) | 9,11-脱氢脱氧皮甾醇的C3-C1017α-酯用作抗促性腺激素剂的用途 | |
Endo et al. | Intravaginal administration of progesterone using a new technique for sustained drug release in goats | |
Lewis et al. | The effect of stilbestrol and anterior pituitary extract upon lactation in goats | |
US20200375980A1 (en) | Veterinary antiprolactinic composition | |
Reynolds et al. | The effect of trenbolone acetate on the bovine oestrous cycle | |
US3743730A (en) | Method of inducing labor and parturition in animals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |